TY - JOUR
T1 - The pattern of peritoneal colorectal metastasis predicts survival after cytoreductive surgery and hyperthermic intra-peritoneal chemotherapy
AU - Assaf, Dan
AU - Mor, Eyal
AU - Laks, Shachar
AU - Zohar, Nitzan
AU - Benvenisti, Haggai
AU - Hazzan, David
AU - Segev, Lior
AU - Akopyan, Olga Klebanov
AU - Shacham-Shmueli, Einat
AU - Margalit, Ofer
AU - Halpern, Naama
AU - Boursi, Ben
AU - Ben-Yaacov, Almog
AU - Nissan, Aviram
AU - Adileh, Mohammad
N1 - Publisher Copyright:
© 2021 Elsevier Ltd, BASO ~ The Association for Cancer Surgery, and the European Society of Surgical Oncology
PY - 2022/1
Y1 - 2022/1
N2 - Background: Peritoneal cancer index (PCI) has been used reliably to prognosticate patients with peritoneal metastasis, however, it fails to describe the patterns of peritoneal spread and to correlate these patterns to survival outcomes. We aim to define the scattered peritoneal spread (SPS) as a pattern associated with worse survival in colorectal peritoneal metastasis. Methods: A retrospective analysis of metastatic colorectal cancer patients from a prospectively maintained database of peritoneal surface malignances (n = 280) between 2015 and 2020. SPS was defined by the presence of at least two distant and non-contiguous PCI regions. We compared patients with SPS (n = 73) and clustered peritoneal spread (CPS) (n = 88) for demographics, perioperative and survival outcomes. Results: No difference in demographics or post-operative course was noted between the groups. The median follow-up was 15.4 months (0.4–70.8 months). Worse disease-free survival (DFS) in the SPS group with an estimated median of 8.2 months compared to 22.5 months in the CPS spread group, (p = 0.001). The estimated median overall survival (OS) for SPS group was 35.7 months whereas in the CPS group the median was not reached (p = 0.025). The same effect of SPS was preserved even after stratification of PCI. Conclusions: We defined and described the association of the peritoneal spread pattern to survival outcomes. SPS patients exhibit worse DFS and OS independent of the PCI level. Integration of malignant spread pattern into prognostication models along with PCI may aid in predicting oncological outcomes.
AB - Background: Peritoneal cancer index (PCI) has been used reliably to prognosticate patients with peritoneal metastasis, however, it fails to describe the patterns of peritoneal spread and to correlate these patterns to survival outcomes. We aim to define the scattered peritoneal spread (SPS) as a pattern associated with worse survival in colorectal peritoneal metastasis. Methods: A retrospective analysis of metastatic colorectal cancer patients from a prospectively maintained database of peritoneal surface malignances (n = 280) between 2015 and 2020. SPS was defined by the presence of at least two distant and non-contiguous PCI regions. We compared patients with SPS (n = 73) and clustered peritoneal spread (CPS) (n = 88) for demographics, perioperative and survival outcomes. Results: No difference in demographics or post-operative course was noted between the groups. The median follow-up was 15.4 months (0.4–70.8 months). Worse disease-free survival (DFS) in the SPS group with an estimated median of 8.2 months compared to 22.5 months in the CPS spread group, (p = 0.001). The estimated median overall survival (OS) for SPS group was 35.7 months whereas in the CPS group the median was not reached (p = 0.025). The same effect of SPS was preserved even after stratification of PCI. Conclusions: We defined and described the association of the peritoneal spread pattern to survival outcomes. SPS patients exhibit worse DFS and OS independent of the PCI level. Integration of malignant spread pattern into prognostication models along with PCI may aid in predicting oncological outcomes.
KW - Colorectal metastasis
KW - Cytoreduction
KW - HIPEC
KW - PCI
KW - Scattered spread
UR - http://www.scopus.com/inward/record.url?scp=85114351320&partnerID=8YFLogxK
U2 - 10.1016/j.ejso.2021.08.023
DO - 10.1016/j.ejso.2021.08.023
M3 - ???researchoutput.researchoutputtypes.contributiontojournal.article???
C2 - 34489120
AN - SCOPUS:85114351320
SN - 0748-7983
VL - 48
SP - 197
EP - 203
JO - European Journal of Surgical Oncology
JF - European Journal of Surgical Oncology
IS - 1
ER -